| 376 |
396: Covalent Binding, Protein |
397: Response, Keratinocytes |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 378 |
397: Response, Keratinocytes |
398: Activation, Dendritic Cells |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 395 |
228: demethylation, PPARg promoter |
408: reduction in ovarian granulosa cells, Aromatase (Cyp19a1) |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 380 |
397: Response, Keratinocytes |
272: Activation/Proliferation, T-cells |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 383 |
279: Thyroperoxidase, Inhibition |
402: Cognitive function, decreased |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 393 |
405: disrupted, ovarian cycle |
330: Decrease, Fertility |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 389 |
168: Decreased, Lymphocytes |
323: Increased, Disease susceptibility |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 168 |
158: N/A, Interferences with SH-/selen-proteins |
130: Depletion, GSH |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 228 |
201: Binding of antagonist, NMDA receptors |
341: Impairment, Learning and memory |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 215 |
195: Inhibition, NMDARs |
191: Neuronal dysfunction |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 214 |
195: Inhibition, NMDARs |
341: Impairment, Learning and memory |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 210 |
191: Neuronal dysfunction |
188: Neuroinflammation |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 200 |
351: Increased Mortality |
361: Decline, Population |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 199 |
350: Increase, Mortality |
361: Decline, Population |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 198 |
350: Increase, Mortality |
328: Decrease, Fecundity |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 197 |
183: Abnormal, Morphogenesis |
366: Increased, Structural malformations |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 196 |
183: Abnormal, Morphogenesis |
342: Increased, Lethality |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 88 |
75: N/A, Covalent binding to protein, possibly lysine residue |
151: Activation, Inflammatory cytokines, chemokines, cytoprotective gene pathways |
Nov 29, 2016 |
Sep 24, 2020 |
None
|
| 147 |
134: Increase, Kupffer cell activation |
276: Up Regulation, TGFbeta1 expression |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 146 |
134: Increase, Kupffer cell activation |
209: Peptide Oxidation |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 135 |
328: Decrease, Fecundity |
361: Decline, Population |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 96 |
80: Up Regulation, CYP1A1 |
209: Peptide Oxidation |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 104 |
84: Up Regulation, CYP1B1 |
3: Reduction, 17beta-estradiol synthesis by ovarian granulosa cells |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 116 |
103: Increase, EcR hyperactivation |
60: Induction, Chitin degradation and resorption |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 360 |
387: Binding of agonist, NMDARs |
388: Overactivation, NMDARs |
Nov 29, 2016 |
Nov 29, 2016 |
None
|